Pharmaceuticals
EU High Court Upholds $63 Million Fine Against AstraZeneca
Fine levied for lying on patent applications to member states in an effort to keep the generic version of an ulcer med off the market
Who Decides What a Drug Is For -- The Manufacturer or the Government?
Court rules you can't convict a salesman for recommending a medicine to doctors for purposes the FDA hadn't approved
US Firm Won't Enforce AIDS Drug Patent in Poor Countries
Will allow for manufacture and sale of cheaper generic versions without fear
SAC Capital Manager Arrested for Insider Trading
Founder of company also linked to scheme to profit off secret info about drug testing
Maryland Pharmaceutical Regulator Rejects Calls for Federal Involvement
A meningitis scare has the usual suspects calling for more federal involvement
US Attempting to Shut Down Canada Drug Sites
Internet pharmacy distributed counterfeit cancer drug
FDA Starts Campaign Warning About Online Pharmacies
Thinks Americans are too dumb to realize the risks
Manufacturer Won't Sell Drug for Use in Executions
Setback for states looking for alternatives to other drugs that companies have stopped selling to them
Thalidomide Manufacturer Apologizes for Birth Defects 50 Years Later
The CEO of the Gurenthal Group apologized for manufacturing an anti-morning sickness pill that led to thousands of birth defects
Drug Company to pay $181 Million over Unauthorized Marketing
Janssen promoted antipsychotic drug as also helping with anxiety and anger management
Hope for Men: Male Contraceptive Pill on Horizon
Years of trials and tests still needed.
US Pharmaceuticals Big in The Gray Market
A joint Congressional investigation has found that some US pharmacies use the "gray market" to increase profits by thousands of percent.
Among the Biotech Conventioneers
A dispatch on the value of failed drugs, new vaccines against superbugs, and the prospect of a molecular stethoscope.
Will Comparative Effectiveness Research Kill More People Than It Helps?
Consumers, not bureaucrats, should make healthcare decisions.
Citizen Science, Microfinanced Research, Patent Trolls, and Pharma Prizes
A final dispatch from the Open Science Summit.
